Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 392

1.

Mechanisms of GII.4 norovirus persistence in human populations.

Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, Vinje J, Baric RS.

PLoS Med. 2008 Feb;5(2):e31. doi: 10.1371/journal.pmed.0050031.

2.

[Noroviruses--tactic of spread].

Gospodarek E, Zalas-Wiecek P.

Przegl Epidemiol. 2009;63(1):5-9. Review. Polish.

PMID:
19522218
3.

Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.

Debbink K, Donaldson EF, Lindesmith LC, Baric RS.

J Virol. 2012 Jan;86(2):1214-26. doi: 10.1128/JVI.06189-11.

4.

Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations.

Donaldson EF, Lindesmith LC, Lobue AD, Baric RS.

Immunol Rev. 2008 Oct;225:190-211. doi: 10.1111/j.1600-065X.2008.00680.x. Review.

PMID:
18837783
5.

Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Parra GI, Abente EJ, Sandoval-Jaime C, Sosnovtsev SV, Bok K, Green KY.

J Virol. 2012 Jul;86(13):7414-26. doi: 10.1128/JVI.06729-11.

6.

Norovirus GII.4 strain antigenic variation.

Lindesmith LC, Donaldson EF, Baric RS.

J Virol. 2011 Jan;85(1):231-42. doi: 10.1128/JVI.01364-10.

7.

Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.

Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, Debbink K, Lanzavecchia A, Baric RS.

PLoS Pathog. 2012;8(5):e1002705. doi: 10.1371/journal.ppat.1002705.

8.

Genogroup IV and VI canine noroviruses interact with histo-blood group antigens.

Caddy S, Breiman A, le Pendu J, Goodfellow I.

J Virol. 2014 Sep;88(18):10377-91. doi: 10.1128/JVI.01008-14.

9.

Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution.

Tan M, Xia M, Chen Y, Bu W, Hegde RS, Meller J, Li X, Jiang X.

PLoS One. 2009;4(4):e5058. doi: 10.1371/journal.pone.0005058.

10.

Within-host evolution results in antigenically distinct GII.4 noroviruses.

Debbink K, Lindesmith LC, Ferris MT, Swanstrom J, Beltramello M, Corti D, Lanzavecchia A, Baric RS.

J Virol. 2014 Jul;88(13):7244-55. doi: 10.1128/JVI.00203-14.

11.

Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution.

Shanker S, Choi JM, Sankaran B, Atmar RL, Estes MK, Prasad BV.

J Virol. 2011 Sep;85(17):8635-45. doi: 10.1128/JVI.00848-11.

12.

Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.

Debbink K, Lindesmith LC, Donaldson EF, Swanstrom J, Baric RS.

J Virol. 2014 Jul;88(13):7256-66. doi: 10.1128/JVI.00785-14.

13.

Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses.

Shanker S, Czako R, Sankaran B, Atmar RL, Estes MK, Prasad BV.

J Virol. 2014 Jun;88(11):6168-80. doi: 10.1128/JVI.00201-14.

14.

Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.

Yang Y, Xia M, Tan M, Huang P, Zhong W, Pang XL, Lee BE, Meller J, Wang T, Jiang X.

J Virol. 2010 Sep;84(18):9595-607. doi: 10.1128/JVI.02614-09.

15.

Human noroviruses' fondness for histo-blood group antigens.

Singh BK, Leuthold MM, Hansman GS.

J Virol. 2015 Feb;89(4):2024-40. doi: 10.1128/JVI.02968-14.

16.

Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Mahar JE, Donker NC, Bok K, Talbo GH, Green KY, Kirkwood CD.

J Virol. 2014 Feb;88(4):1942-52. doi: 10.1128/JVI.02992-13.

17.

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera.

Cannon JL, Lindesmith LC, Donaldson EF, Saxe L, Baric RS, Vinjé J.

J Virol. 2009 Jun;83(11):5363-74. doi: 10.1128/JVI.02518-08.

18.

Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.

Lindesmith LC, Debbink K, Swanstrom J, Vinjé J, Costantini V, Baric RS, Donaldson EF.

J Virol. 2012 Jan;86(2):873-83. doi: 10.1128/JVI.06200-11.

19.

Characterization of emerging GII.g/GII.12 noroviruses from a gastroenteritis outbreak in the United States in 2010.

Takanashi S, Wang Q, Chen N, Shen Q, Jung K, Zhang Z, Yokoyama M, Lindesmith LC, Baric RS, Saif LJ.

J Clin Microbiol. 2011 Sep;49(9):3234-44. doi: 10.1128/JCM.00305-11.

20.

Genotype distribution of norovirus around the emergence of Sydney_2012 and the antigenic drift of contemporary GII.4 epidemic strains.

Zhang J, Shen Z, Zhu Z, Zhang W, Chen H, Qian F, Chen H, Wang G, Wang M, Hu Y, Yuan Z.

J Clin Virol. 2015 Nov;72:95-101. doi: 10.1016/j.jcv.2015.09.009.

PMID:
26476326
Items per page

Supplemental Content

Support Center